New Health Measures in CKD Management
HCPLive
DECEMBER 30, 2024
Panelists discuss the new health measures relevant to chronic kidney disease (CKD) management and their significance in improving patient care and outcomes.
HCPLive
DECEMBER 30, 2024
Panelists discuss the new health measures relevant to chronic kidney disease (CKD) management and their significance in improving patient care and outcomes.
Med Page Today
DECEMBER 31, 2024
(MedPage Today) -- A three-step process underscores new clinical practice guidelines for primary and specialty care clinicians to evaluate patients who may have cognitive impairment or dementia due to Alzheimer's or a related disease. In broad.
Ken Grauer, MD
DECEMBER 28, 2024
I was sent the ECG in Figure-1 told only that the patient was an older adult who reported dizziness with activity. QUESTIONS: What is the rhythm? ( HINT: There are at least 4 important findings that should be noted ). Is there AV block? Figure-1: The initial ECG in today's case. ( To improve visualization I've digitized the original ECG using PMcardio ).
Dr. Paddy Barrett
DECEMBER 27, 2024
I am a little odd. At least, according to my wife, anyway. I love Mondays and January. Everyone else seems to dislike these calendar milestones, but for me, they represent a fresh start and the opportunity to reassess the work that needs to be done. As we approach the end of the year and prepare to set out into the next one, the most common New Year resolutions are often health-related.
Med Page Today
DECEMBER 26, 2024
(MedPage Today) -- Persistently short sleep duration during and after pregnancy was tied to a greater risk for adverse cardiometabolic outcomes, a secondary analysis of cohort study data showed. Women who said they slept fewer than 7 hours a night.
Medical Xpress - Cardiology
DECEMBER 27, 2024
A research team led by Prof. Chen Yan at the University of Science and Technology of China (USTC) has taken a leap forward in cardiovascular health monitoring. They have developed a non-invasive radio frequency (RF)-based system capable of monitoring heart rate variability (HRV) with clinical-grade accuracy over extended periods.
Heart Sisters
DECEMBER 29, 2024
Was this particular article the most popular of 2024 because my HEART SISTERS readers aren't getting clear jargon-free, patient-friendly answers from their doctors?
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
HCPLive
DECEMBER 27, 2024
A look back at some of our top coverage in ophthalmology from 2024, including pipeline news and FDA approvals.
The New England Journal of Medicine
JANUARY 1, 2025
A randomized trial of the factor XIa inhibitor asundexian was stopped early owing to a higher incidence of stroke or systemic embolism than with apixaban therapy among patients with atrial fibrillation.
MIBHS
DECEMBER 27, 2024
Heart bypass surgery, formally known as coronary artery bypass graft (CABG) surgery, is a life-saving procedure that helps improve blood flow to the heart when coronary arteries become blocked or narrowed. This surgery involves creating new pathways for blood to flow to the heart muscle by bypassing the blocked sections of the arteries. While this procedure can significantly enhance heart function and reduce symptoms of heart disease, it does come with potential risks and complications.
Nature Reviews - Cardiology
JANUARY 1, 2025
Nature Reviews Cardiology, Published online: 02 January 2025; doi:10.1038/s41569-024-01109-8 In this Review, Lavine and colleagues describe the known subsets of cardiac macrophages, highlighting newly identified macrophage states and associated cellular neighbourhoods, and discuss the roles of cardiac macrophages in homeostasis and disease, including in inflammation, fibrosis, age-associated pathologies, mechanosensing, efferocytosis, angiogenesis, arrhythmias and transplant allograft survival.
HCPLive
DECEMBER 30, 2024
Panelists discuss how current treatments for IgA nephropathy often fall short in addressing the root cause, specifically abnormal IgA production and deposition, and highlight the consequences of prioritizing symptom management, such as proteinuria reduction, over targeting the diseases underlying pathology.
Med Page Today
DECEMBER 28, 2024
(MedPage Today) -- In January, we reported on the FDA clearing GLP-1 receptor agonists of suicidality risk following a preliminary evaluation. In this report, we follow up on what has happened since. Not long after the FDA wrapped its preliminary.
Medical Xpress - Cardiology
DECEMBER 27, 2024
A Korea Institute of Science and Technology (KIST) research team has developed a novel stent surface treatment technology using laser patterning. This technology promotes endothelial cell growth while inhibiting smooth muscle cell dedifferentiation in blood vessels.
Dr. Smith's ECG Blog
DECEMBER 29, 2024
Dizziness is so unlikely to be OMI without an obvious ECG, that I am going to pretend that this patient presented with chest pain. The PMCardio Queen of Hearts app asks you, before giving an interpretation of OMI ("STEMI-Equivalent"), whether the patient's clinical presentation is high risk for OMI. If no, then she will tell you that the case is outside of the intended use group.
Nature Reviews - Cardiology
JANUARY 1, 2025
Nature Reviews Cardiology, Published online: 02 January 2025; doi:10.1038/s41569-024-01103-0 Vascular cells are finely regulated by complex microenvironments, including biomechanical signals from the extracellular matrix. In this Review, Kong and colleagues describe the role of the extracellular matrix in vascular development, ageing and disease, and highlight the potential of novel therapies targeting this fine-tuned network.
HCPLive
DECEMBER 26, 2024
From groundbreaking therapies to ethical dilemmas, HCPLives top podcasts of 2024 delivered expert insights and human stories across medicine.
Med Page Today
DECEMBER 27, 2024
(MedPage Today) -- In August, we reported on the decision by the Centers for Medicare & Medicaid Services (CMS) to not pursue a proposed Medicare policy that would have restricted coverage of a blood test used to monitor for transplant rejection.
The New England Journal of Medicine
JANUARY 1, 2025
Among patients with transthyretin amyloidosis with cardiomyopathy, the risk of death from any cause and recurrent cardiovascular events was lower with vutrisiran treatment than with placebo.
Dr. Paddy Barrett
DECEMBER 28, 2024
"Frustrated, lost and confused." That was the main feedback I got from thousands of readers when I asked them about their experience working with existing healthcare systems to implement a plan to prevent heart disease. This is not good. Heart disease is the leading cause of death worldwide, and with the right approaches, 80% or more can be prevented at an early age.
Nature Reviews - Cardiology
JANUARY 1, 2025
Nature Reviews Cardiology, Published online: 02 January 2025; doi:10.1038/s41569-024-01111-0 In this Review, Born and colleagues present insights into the role of apolipoprotein B-containing lipoproteins in atherogenesis, with an emphasis on the mechanisms leading to atherosclerotic plaque initiation and growth. They describe the causative role of LDL at the early stages of atherogenesis and discuss the relative atherogenicity of lipoprotein(a) and triglyceride-rich lipoproteins.
HCPLive
JANUARY 1, 2025
Patients hospitalized for severe COVID-19 had an accelerated eGFR decline relative to those with pneumonia due to other infections.
Med Page Today
DECEMBER 31, 2024
(MedPage Today) -- MedPage Today's enterprise and investigative team covers a lot of ground. We jump in when there's breaking news in healthcare. We write second-day stories on the implications of that news. We craft compelling feature stories.
Journal of Cardiothoracic Surgery
DECEMBER 30, 2024
Epithelioid hemangioendothelioma (EHE) is an uncommon vascular malignancy characterized by an unpredictable clinical course and a high potential for recurrence and metastasis. The lack of standard treatment gu.
Becker's Hospital Review - Cardiology
DECEMBER 26, 2024
Some acute heart failure patients can be safely and successfully treated at home, according to a research letter published Nov. 16 in JACC: Heart Failure.
Nature Reviews - Cardiology
JANUARY 1, 2025
Nature Reviews Cardiology, Published online: 02 January 2025; doi:10.1038/s41569-024-01110-1 In this Review, Dey and colleagues explore the pathobiology of coronary atherosclerotic plaques and perivascular adipose tissue, describe their phenotyping with computed tomography coronary angiography, and discuss potential future applications in clinical risk prediction and patient management.
HCPLive
DECEMBER 27, 2024
2024 was a historic year in hepatology, characterized by notable hepatic FDA approvals, pipeline developments, new WHO HBV guidelines, and more.
Med Page Today
DECEMBER 30, 2024
(MedPage Today) -- Atherosclerosis progression was more than twice as common in younger people with systemic lupus erythematosus (SLE) than in healthy controls in a prospective study from Greece, but the rate difference narrowed substantially with.
Medical Xpress - Cardiology
DECEMBER 26, 2024
Female stroke victims are less likely than men to take drugs that could lower their odds of a second stroke.
ECG Cases
DECEMBER 31, 2024
Based on a blend of number of listens, views, feedback from listeners, website traffic and personal faves, EM Cases Top 10 Best of 2024 podcasts, videos and blog posts. The post EM Cases Top 10 Best of 2024 appeared first on Emergency Medicine Cases.
Dr. Paddy Barrett
DECEMBER 30, 2024
When medical interventions are being evaluated for cost-effectiveness, the benchmark for one additional quality year of life is $50,000. This is known as a QALY or Quality Adjusted Life Year. If the intervention costs less than $50,000 per year to provide an additional quality year, it is considered cost-effective. Of course, this is a somewhat arbitrary figure, but we have to start somewhere.
HCPLive
DECEMBER 26, 2024
The proposed rule seeks to establish and require standardized testing methods to detect and identify asbestos in cosmetic products with talc.
Med Page Today
DECEMBER 28, 2024
(MedPage Today) -- TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech University Health Sciences Center.
Nature Reviews - Cardiology
JANUARY 1, 2025
Nature Reviews Cardiology, Published online: 02 January 2025; doi:10.1038/s41569-024-01114-x In this Review, Heusch and Kleinbongard describe the deleterious and protective roles of the spleen in the inflammatory processes of atherosclerosis, myocardial infarction and heart failure, and highlight the translational potential of the cardioprotective functions of the spleen for the treatment of patients with ischaemic heart disease.
Frontiers in Cardiovascular Medicine
JANUARY 1, 2025
BackgroundAtrial fibrillation (AF) is a prevalent cardiac arrhythmia, with ventricular rate control being a critical therapeutic target. However, the optimal range for ventricular rate control remains unclear. Additionally, the relationship between different levels of ventricular rate control and cardiac remodeling in patients with atrial fibrillation remains unclear.ObjectiveThis study aims to explore the relationship between different levels of heart rate control and cardiac remodeling in pati
Journal of Cardiothoracic Surgery
DECEMBER 30, 2024
Bronchial artery pseudoaneurysm is a rare vascular disorder, and cases of bronchial pseudoaneurysms reported after lung surgery are even rarer. The number of reported cases is very limited due to the unclear p.
HCPLive
DECEMBER 28, 2024
The field of dermatology saw a wide array of notable developments this year, with highlights including FDA approvals as well as notable clinical trial results.
Let's personalize your content